AEON Biopharma Inc.

0.75
0.02 (2.74%)
At close: Mar 18, 2025, 3:59 PM
0.74
-1.05%
After-hours: Mar 18, 2025, 08:00 PM EDT

AEON Biopharma Ratios Statement

Year FY23 FY22 FY21 FY20 FY19
PE Ratio n/a n/a -261.88 -297.79 56.68
PEG Ratio n/a n/a -18.75 2.50 n/a
PS Ratio n/a n/a n/a 3.89K 2.92K
PB Ratio n/a n/a -62.02 -47.06 -145.96
P/FCF Ratio n/a n/a -509.39 -1.04K -211.15
P/OCF Ratio n/a n/a -512.44 -1.04K -219.14
OCF/S Ratio n/a n/a n/a -3.76 -13.32
Debt / Equity Ratio -0.00 -0.46 -0.37 -0.35 -0.45
Quick Ratio 0.48 0.12 0.25 4.85 6.41
Current Ratio 0.48 0.12 0.25 4.85 6.41
Asset Turnover n/a n/a n/a 0.12 0.03
Interest Coverage n/a n/a n/a -1.09K -7.22
Return on Equity (ROE) n/a 0.18 0.24 0.16 -2.58
Return on Assets (ROA) n/a -4.88 -8.64 -1.55 1.51
Return on Capital (ROIC) n/a 0.67 4.58 -0.96 -0.56
Dividend Yield n/a n/a n/a n/a n/a
Payout Ratio n/a n/a n/a n/a n/a
Gross Profit Margin n/a n/a n/a 100.00% 1.00%
Net Profit Margin n/a n/a n/a -1.31K% 51.51%
Pretax Profit Margin n/a n/a n/a -1.31K% 43.39%
Operating Profit Margin n/a n/a n/a -650.83% -16.08%
FCF Margin n/a n/a -375.73% -1.38K% n/a
EBITDA Margin n/a n/a -879.35% -1.5K% n/a